RADIOTHER ONCOL 润色咨询

RADIOTHERAPY AND ONCOLOGY

出版年份:1983 年文章数:4073 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:19.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2016-12-29 么么黑眼圈

    怎样力争呢?修了之后再重投?shiliangrong 2015-10-26 发表::
    有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。

    shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2016-10-14 bobo博

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2016-08-25 ms2798897682501839

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2015-10-26 shiliangrong

    有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2015-08-07 DrYCheng

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2015-08-07 DrYCheng

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2014-07-06 匿名用户

    审稿速度:3.0
    经验分享:投了两个多月,被拒了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2014-05-07 匿名用户

    with editor一周了,一点反应都没有,大家有没有什么反应?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2014-04-09 匿名用户

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=531192, encodeId=ffc2531192a9, content=怎样力争呢?修了之后再重投?<span class="quote">shiliangrong 2015-10-26 发表::<br>有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。</span>, beContent=shiliangrong 2015-10-26 发表:: 有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ed31928936, createdName=么么黑眼圈, createdTime=Thu Dec 29 01:26:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528215, encodeId=887452821589, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:2015年底投了一篇临床类文章,一审近两个月,三个审稿人提了大大小小30多个问题,问题非常专业。一个审稿人建议拒稿,两个建议反修,副主编给了revise,没写大修还是小修。 两个月后修回,二审2个月,一个审稿人同意接受,一个又提了五六个问题,还有一个仍建议拒搞,最后还是被拒搞了。然后按审稿人建议修改文章后投其他杂志就接收了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07631714075, createdName=bobo博, createdTime=Fri Oct 14 14:39:00 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833481, encodeId=25e08334817a, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:审稿人很有水平,审稿很专业,2月中旬投,3月底拒稿。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85575414075, createdName=ms2798897682501839, createdTime=Thu Aug 25 23:07:07 CST 2016, time=2016-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516317, encodeId=9f4351631e0c, content=有幸中了一篇关于放射性粒子的临床应用文章7月投出,6周后审稿结束,要求大修,花了两周修好,补充了一些亚组统计分析的数据,再次审稿,4周后通知小修,审稿人纠结于我们的放射剂量参数,再次修回后编辑没有再发外审而直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=265339670, createdName=shiliangrong, createdTime=Mon Oct 26 07:10:00 CST 2015, time=2015-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514316, encodeId=a6b7514316b4, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:37:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514315, encodeId=a58d5143155c, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:2月中旬投,3月底拒稿。老板力争重投,于5月中旬再投,7月中旬修回,一周内返修给杂志,8月初(今天)接收:-))) 老牌杂志,欧洲放疗界老大绿皮(北美是红皮), 审稿人还是非常有水平的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab71637593, createdName=DrYCheng, createdTime=Fri Aug 07 04:36:00 CST 2015, time=2015-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503956, encodeId=a8775039567a, content=审稿速度:3.0<br>经验分享:投了两个多月,被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Jul 06 10:04:00 CST 2014, time=2014-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502764, encodeId=88c8502e6483, content=with editor一周了,一点反应都没有,大家有没有什么反应?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 07 20:53:00 CST 2014, time=2014-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502246, encodeId=dd7d5022465a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:Submitted to Journal已经1月了,据说主编增加成2个,就开始扯皮了,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=393, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Apr 09 09:16:00 CST 2014, time=2014-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=499697, encodeId=233449969eb1, content=under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Nov 06 15:53:00 CST 2013, time=2013-11-06, status=1, ipAttribution=)]
    2013-11-06 匿名用户

    under review已经三月了,倒底有没有戏啊,我的时间啊!!!!!

    0

共69条页码: 4/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分